vs
Side-by-side financial comparison of Bolt Biotherapeutics, Inc. (BOLT) and Edible Garden AG Inc (EDBL). Click either name above to swap in a different company.
Edible Garden AG Inc is the larger business by last-quarter revenue ($4.1M vs $2.5M, roughly 1.7× Bolt Biotherapeutics, Inc.). Over the past eight quarters, Edible Garden AG Inc's revenue compounded faster (14.8% CAGR vs -31.2%).
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
Edible Garden AG Inc is a U.S.-based sustainable agricultural company specializing in hydroponically grown fresh organic herbs, leafy greens, and specialty vegetables. It distributes its pesticide-free produce to leading grocery retailers, food service operators, and direct-to-consumer platforms across North America, prioritizing eco-friendly, low-water farming practices.
BOLT vs EDBL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5M | $4.1M |
| Net Profit | $-6.6M | — |
| Gross Margin | — | -29.0% |
| Operating Margin | -283.4% | -138.6% |
| Net Margin | -265.2% | — |
| Revenue YoY | — | 6.6% |
| Net Profit YoY | 58.4% | — |
| EPS (diluted) | $-9.38 | $-109.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5M | $4.1M | ||
| Q3 25 | $2.2M | $2.8M | ||
| Q2 25 | $1.8M | $3.1M | ||
| Q1 25 | $1.2M | $2.7M | ||
| Q4 24 | $0 | $3.9M | ||
| Q3 24 | $1.1M | $2.6M | ||
| Q2 24 | $1.3M | $4.3M | ||
| Q1 24 | $5.3M | $3.1M |
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-7.1M | $-4.0M | ||
| Q2 25 | $-8.6M | $-4.0M | ||
| Q1 25 | $-11.0M | $-3.3M | ||
| Q4 24 | $-15.9M | $-3.1M | ||
| Q3 24 | $-15.2M | $-2.1M | ||
| Q2 24 | $-21.2M | $-1.9M | ||
| Q1 24 | $-10.8M | $-4.0M |
| Q4 25 | — | -29.0% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | — | 20.2% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 27.1% | ||
| Q2 24 | — | 36.7% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | -283.4% | -138.6% | ||
| Q3 25 | -355.1% | -126.3% | ||
| Q2 25 | -510.5% | -114.2% | ||
| Q1 25 | -991.4% | -107.7% | ||
| Q4 24 | — | -70.8% | ||
| Q3 24 | -1441.1% | -57.7% | ||
| Q2 24 | -1772.3% | -27.7% | ||
| Q1 24 | -324.1% | -123.3% |
| Q4 25 | -265.2% | — | ||
| Q3 25 | -329.4% | -143.6% | ||
| Q2 25 | -474.6% | -128.5% | ||
| Q1 25 | -903.4% | -122.3% | ||
| Q4 24 | — | -79.5% | ||
| Q3 24 | -1330.1% | -79.8% | ||
| Q2 24 | -1662.4% | -45.3% | ||
| Q1 24 | -205.0% | -127.0% |
| Q4 25 | $-9.38 | $-109.97 | ||
| Q3 25 | $-3.72 | $1.38 | ||
| Q2 25 | $-4.46 | $-6.58 | ||
| Q1 25 | $-0.29 | $-2.47 | ||
| Q4 24 | $-13.73 | $-330.78 | ||
| Q3 24 | $-7.93 | $16.32 | ||
| Q2 24 | $-11.12 | $-30.02 | ||
| Q1 24 | $-0.28 | $-341.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.5M | — |
| Total DebtLower is stronger | — | $1.7M |
| Stockholders' EquityBook value | $26.5M | $12.5M |
| Total Assets | $56.7M | $20.6M |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.5M | — | ||
| Q3 25 | $31.9M | — | ||
| Q2 25 | $34.8M | — | ||
| Q1 25 | $38.8M | — | ||
| Q4 24 | $47.3M | — | ||
| Q3 24 | $53.8M | — | ||
| Q2 24 | $73.7M | — | ||
| Q1 24 | $91.3M | — |
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $2.7M | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $26.5M | $12.5M | ||
| Q3 25 | $32.1M | $12.9M | ||
| Q2 25 | $38.8M | $1.6M | ||
| Q1 25 | $46.8M | $1.9M | ||
| Q4 24 | $57.2M | $4.1M | ||
| Q3 24 | $72.0M | $3.3M | ||
| Q2 24 | $85.9M | $511.0K | ||
| Q1 24 | $104.2M | $-4.1M |
| Q4 25 | $56.7M | $20.6M | ||
| Q3 25 | $65.1M | $20.1M | ||
| Q2 25 | $75.5M | $21.8M | ||
| Q1 25 | $85.9M | $8.5M | ||
| Q4 24 | $99.6M | $11.9M | ||
| Q3 24 | $109.3M | $8.9M | ||
| Q2 24 | $124.2M | $9.9M | ||
| Q1 24 | $142.9M | $6.3M |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.2M | $-2.7M |
| Free Cash FlowOCF − Capex | — | $-2.8M |
| FCF MarginFCF / Revenue | — | -66.8% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-12.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.2M | $-2.7M | ||
| Q3 25 | $-9.7M | $-2.4M | ||
| Q2 25 | $-9.6M | $-3.4M | ||
| Q1 25 | $-13.4M | $-3.3M | ||
| Q4 24 | $-14.4M | $-1.8M | ||
| Q3 24 | $-14.0M | $-1.1M | ||
| Q2 24 | $-16.1M | $-4.6M | ||
| Q1 24 | $-16.8M | $-1.1M |
| Q4 25 | — | $-2.8M | ||
| Q3 25 | — | $-2.8M | ||
| Q2 25 | — | $-3.5M | ||
| Q1 25 | — | $-3.4M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | $-14.0M | $-1.1M | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-1.1M |
| Q4 25 | — | -66.8% | ||
| Q3 25 | — | -98.9% | ||
| Q2 25 | — | -110.8% | ||
| Q1 25 | — | -125.5% | ||
| Q4 24 | — | -48.6% | ||
| Q3 24 | -1227.6% | -43.4% | ||
| Q2 24 | — | -110.2% | ||
| Q1 24 | — | -35.6% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 3.6% | 0.4% | ||
| Q2 24 | 0.0% | 2.6% | ||
| Q1 24 | 0.0% | 1.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BOLT
Segment breakdown not available.
EDBL
| Herbs Produce Floral | $3.6M | 86% |
| Other | $576.0K | 14% |
